Evidence map›Paper›PMID 30651372›Full record

ArticleMolecular cancer research : MCR2019

The Germline Variants rs61757955 and rs34988193 Are Predictive of Survival in Lower Grade Glioma Patients.

Ajay Chatrath, Manjari Kiran, Pankaj Kumar, Aakrosh Ratan, Anindya Dutta

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer research : MCR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Overview of Research on Germline Genetic Variation in Immune Genes and Cancer Outcomes.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  3. Germline Variants That Affect Tumor Progression.Trends in genetics : TIG · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ajay ChatrathDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia.
Manjari KiranDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia.
Pankaj KumarDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia.
Aakrosh RatanCenter for Public Health Genomics, University of Virginia, Charlottesville, Virginia.ORCID 0000-0002-0782-3056
Anindya DuttaDepartment of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia. ad8q@virginia.edu.ORCID 0000-0002-4319-0073
University of Virginia · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007267 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI GARCIA-BLANCO, MARIANO A. · 1985 to 2024
$13.4M
The role of MCM8-9 in genomic instability of cancersR01CA060499 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Anindya Dutta · 1994 to 2026
$8.6M
Summer Research Experience in Cancer(SuRE-C)R25CA206972 · NCI · UNIVERSITY OF VIRGINIA · PI ADRIAN J HALME, Hui Zong · 2017 to 2026
$2.0M
Effect of anti-S phase agents on human chromosomesR01CA166054 · NCI · UNIVERSITY OF VIRGINIA · PI DUTTA, ANINDYA · 2013 to 2017
$1.6M
NCI NIH HHS HHSN261201400008CNCI NIH HHS HHSN261201500003CNCI NIH HHS HHSN261201500003INCI NIH HHS R01 CA060499NCI NIH HHS R01 CA166054NCI NIH HHS R25 CA206972NIGMS NIH HHS T32 GM007267
6 · The paper itself

Abstract

Lower grade gliomas are invasive brain tumors that are difficult to completely resect neurosurgically. They often recur following resection and progress, resulting in death. Although previous studies have shown that specific germline variants increase the risk of tumor formation, no previous study has screened many germline variants to identify variants predictive of survival in patients with glioma. In this study, we present an approach to identify the small fraction of prognostic germline variants from the pool of over four million variants that we variant called in The Cancer Genome Atlas whole-exome sequencing and RNA sequencing datasets. We identified two germline variants that are predictive of poor patient outcomes by Cox regression, controlling for eleven covariates. rs61757955 is a germline variant found in the 3' UTR of

Indexed as

Germ-Line MutationAdolescentAdultAgedAged, 80 and overBrain NeoplasmsExome SequencingFemaleGliomaGRB2 Adaptor ProteinHumansIntracellular Signaling Peptides and ProteinsMaleMiddle AgedNeoplasm GradingPolymorphism, Single NucleotideANKDD1A protein, humanGRB2 Adaptor ProteinGRB2 protein, humanIntracellular Signaling Peptides and ProteinsTumor Suppressor Proteins

Identifiers

PMID30651372
PMCPMC6497557
OpenAlexW2952182996

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.